DJ AstraZeneca PLC ADR Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slid 0.75% to $67.75 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.12% to 39,807.37 and the NASDAQ Composite Index falling 0.12% to 16,379.46.
The ADR's fall snapped a two-day winning streak.
AstraZeneca PLC ADR closed $8.81 short of its 52-week high ($76.56), which the company achieved on April 25th.
The ADR underperformed when compared to some of its competitors Thursday, as Eli Lilly & Co. $(LLY)$ fell 0.03% to $777.96, Biogen Inc. $(BIIB)$ fell 0.33% to $215.63, and Johnson & Johnson $(JNJ)$ rose 0.15% to $158.19.
Trading volume (3.6 M) remained 2.9 million below its 50-day average volume of 6.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 28, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 28, 2024 17:26 ET (21:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments